Search for: "Sheppard v. State" Results 381 - 400 of 425
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Oct 2022, 4:00 am by Administrator
TOXIC BURDENS AND STATE RESPONSIBILITY In the 1980s, the concept of environmental inequality emerged to stand for the simple premise that environmental degradation does not affect everyone equally. [read post]
3 Oct 2023, 4:40 pm by Tiana Garbett and James Gatto
Copyright Office’s denial of a copyright application for a work created using generative AI due to lack of human authorship (Thaler v. [read post]
13 May 2012, 4:46 pm by Lawrence Higgins
[Link] Sheppard Mullin Richter & Hampton is looking doe a mid-level associate with a CS or EE degree to work at their Palo Alto office. [read post]
15 Nov 2017, 7:39 pm by Wolfgang Demino
 IN THE UNITED STATES DISTRICT COURTFOR THE DISTRICT OF DELAWARECONSUMER FINANCIAL PROTECTION BUREAUPlaintiff,v.THE NATIONAL COLLEGIATE MASTER STUDENT LOAN TRUST, et al.Defendants.C.A. [read post]
22 Feb 2016, 7:18 am by Podhurst Orseck
The high court in in 2012 dismissed as “improvidently granted review” First American v. [read post]
8 Sep 2022, 3:34 pm by Gregory Schick
  The Final Rules state that the Pay Versus Performance Disclosure will not be deemed to be incorporated by reference into any filing under either the Securities Act of 1933 or the Securities Exchange Act of 1934 (the “Exchange Act”) except to the extent that the issuer affirmatively does incorporate it by reference. [read post]
8 Nov 2010, 10:57 am by Roshonda Scipio
. : Columbia University Press, c2010.Constitutional LawKF228.G528 J64 2010Gibbons v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
21 Sep 2020, 12:55 pm by Eric Raphan and Jamie Moelis*
Specifically, the Revised Final Rule does the following: (i) reaffirms the “work-availability” requirement; (ii) reaffirms employer consent for taking FFCRA leave intermittently; (iii) revises the definition of “healthcare provider”; (iv) clarifies that employees must provide required documentation supporting their need for FFCRA leave to their employers as soon as practicable; and (v) corrects an inconsistency regarding when employees may be required to provide… [read post]